The Effects of Cold Liquids on the Swallowing Mechanism in Preterm Infants
|Study Design:||Endpoint Classification: Safety/Efficacy Study
Intervention Model: Single Group Assignment
Masking: Open Label
Primary Purpose: Supportive Care
|Official Title:||A Pilot Study on The Effects of Cold Liquids on the Pharyngeal Swallow in Preterm Infants With Dysphagia.|
- Pharyngeal Swallow Trigger [ Time Frame: <2seconds post swallow trigger ] [ Designated as safety issue: No ]the interval in seconds between the first frame showing barium passing the posterior tongue to the first frame showing laryngeal elevation.
- Laryngeal Penetration, Mild [ Time Frame: <2 seconds post swallow trigger ] [ Designated as safety issue: No ]the occurrence of barium underneath the epiglottis, remaining in the upper 1/3 quadrant of the laryngeal vestibule
- Laryngeal Penetration, Deep [ Time Frame: <2 seconds post swallow trigger ] [ Designated as safety issue: No ]the occurrence of barium underneath the epiglottis, in the laryngeal vestibule to the level of the vocal folds
- Tracheal Aspiration [ Time Frame: <5 seconds post swallow trigger ] [ Designated as safety issue: Yes ]the occurrence of barium below the level of the true vocal cords
- Nasopharyngeal Reflux [ Time Frame: <2 seconds post swallow trigger ] [ Designated as safety issue: No ]the occurrence of barium detected in the nasopharynx, posterior or superior to the velum
- Pharyngeal residue [ Time Frame: <5 seconds post swallow trigger ] [ Designated as safety issue: No ]the presence of residual barium coating the pharyngeal walls, pooling in the vallecula or pyriform sinuses post swallow (absent/mild/severe).
- Silent Aspiration [ Time Frame: <5 seconds post swallow trigger ] [ Designated as safety issue: No ]occurrence of a cough in the presence of aspiration (present/absent)
- Laryngeal Clearance [ Time Frame: <5 seconds post swallow trigger ] [ Designated as safety issue: No ]ability to clear larynx during penetration events (sufficient/insufficient)
- Tracheal Clearance [ Time Frame: <5 seconds post swallow trigger ] [ Designated as safety issue: No ]ability to clear trachea during aspiration events (sufficient/insufficient)
|Study Start Date:||December 2013|
|Estimated Study Completion Date:||September 2015|
|Estimated Primary Completion Date:||August 2015 (Final data collection date for primary outcome measure)|
Experimental: Cold Thin Liquid Barium
Poland Spring Natural Spring Water will be placed in a refrigerator set to 36 °F, this will allow the water to cool to approximately 4-9 °C. As described by several authors, these waters will be used to mix the barium powder (Varibar® Thin Liquid Barium Sulfate for Suspension) to create a thin liquid consistency, with 50% dilution, which is found to be most similar to human milk and infant formula.
the infant will be required to swallow 5 boluses of this cold liquid barium while bottle feeding.
Other: Cold Thin Liquid Barium
Cold thin liquid barium will be fed to the participant from a standard bottle (60ml Similac® Volu-Feeder® with an attached Similac® Infant Nipple and Ring (standard flow)). For this study the refrigerated (cold) thin liquid barium will be measured for an exact temperature of 4-9°C prior to administration to control for any temperature variation. A total of 5 swallows will be visualized and saved electronically on the hospital's electronic storage system.
Other Name: Varibar® Thin Liquid Barium Sulfate for Suspension
Swallowing is a complex task that takes place in the mouth and throat. It involves tiny receptors that gather sensory information about the liquid. Those receptors send a sensory message to the brain, where it is processed. The brain then sends back motor messages to the muscles in the throat regarding what kind of motor movements to do in order to swallow that liquid safely. The motor movements must be carefully timed and coordinated to safely swallow the liquid with out it going near, or into the lungs. When the liquid goes down the wrong tube, or into the lungs, it is called aspiration.
Some infants that are born prematurely end up with swallowing problems when drinking from a bottle. This problem can lead to liquid, such as formula or breastmilk, to be aspirated. This is due to the infant's poor coordination of all the muscles needed to safely swallow.
Researchers have found that changing the sensory characteristics of the liquid alters the motor movements of the swallow. This is because the sensory receptors respond differently to different types if liquids. Studies using adults with swallowing problems has shown that swallowing cold liquids improves some of the swallowing difficulties. Based off of these observations, there are currently several therapies used in Neonatal Intensive Care Units (NICU) nationwide which use cold stimulation to improve swallowing in prematurely born infants, although, there has been no research studies proving it actually works.
The purpose of this study is to assess the effect of cold liquid on the swallow mechanism in preterm infants with swallowing difficulties. A video x-ray procedure, called a Videofluoroscopic Swallow Study (VFSS), is considered the gold standard when assessing the motor movements present in the throat when swallowing. The standard procedure for an infant VFSS involves bottle feeding room temperature liquid barium while looking at the swallow movements obtained from the video x-ray images. After consent is obtained, infants who are assumed to have swallowing difficulties will undergo a "standard" VFSS. If during the study they are found to have swallowing problems, the study protocol will then begin by introducing cold liquid barium from an identical bottle. A total of 5 swallows will be looked at and recorded for review at a later time. The standard procedure for that infant's VFSS will then continue.
The hypothesis is that cold liquids will improve the swallowing movements in premature infants with swallowing difficulty. Information gathered will support the use of cold liquids and cold stimulation in NICUs to help benefit these infants.
Please refer to this study by its ClinicalTrials.gov identifier: NCT01863264
|Contact: Louisa Ferrara, MS, CCC-SLP||516-663-9218||LFerrara@winthrop.org|
|Contact: Nazeeh Hanna, MD||516-663-3853||NHanna@winthrop.org|
|United States, New York|
|Winthrop University Hospital||Recruiting|
|Mineola, New York, United States, 11501|
|Contact: Louisa Ferrara, MS, CCC-SLP 516-663-9218 LFerrara@winthrop.org|
|Sub-Investigator: Louisa Ferrara, MS, CCC-SLP|
|Principal Investigator: Nazeeh Hanna, MD|
|Principal Investigator:||Louisa Ferrara, MS, CCC-SLP||Winthrop University Hospital|